Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Aspirin and Folic Acid for Sudden Sensorineural Hearing Loss
NCT07113158Phase 3Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2026
- Primary completion
- Apr 2029
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aspirin and folic acid in sudden sensorineural hearing loss (SSHL) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Mean Pure Tone Average at 15 days. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
aspirinfolic acid
03
Conditions
sudden sensorineural hearing loss (SSHL)
Beyond the preview
Go deeper on NCT07113158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07113158.